{
    "clinical_study": {
        "@rank": "117546", 
        "arm_group": {
            "arm_group_label": "Tasquinimod", 
            "arm_group_type": "Experimental", 
            "description": "1 capsule (0.25 mg or 0.5 mg or 1 mg) taken orally each day until disease progression, unacceptable toxicity or willingness to stop."
        }, 
        "brief_summary": {
            "textblock": "This is an exploratory proof of concept study to determine the clinical activity of\n      tasquinimod in patients with advanced or metastatic hepatocellular carcinoma (Cohort H),\n      ovarian carcinoma (Cohort O), renal cell carcinoma (Cohort R) and gastric carcinoma (Cohort\n      G) who have progressed after standard therapies."
        }, 
        "brief_title": "A Study With Tasquinimod Treating Patients in Four Independent Cohorts of Hepatocellular, Ovarian, Renal Cell and Gastric Cancers", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Advanced or Metastatic Hepatocellular Cancer", 
            "Advanced or Metastatic Ovarian Cancer", 
            "Metastatic Renal Cell Cancer", 
            "Advanced or Metastatic Gastric Carcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Renal Cell", 
                "Liver Neoplasms", 
                "Stomach Neoplasms", 
                "Ovarian Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "The clinical activity of tasquinimod will be evaluated independently in each individual\n      cohort of patients of the four different tumour types, namely Cohort H, Cohort O, Cohort R\n      and Cohort G respectively."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed metastatic or advanced hepatocellular carcinoma, Barcelona\n             Clinic Liver Cancer stage C or B not amenable to locoregional therapy or refractory\n             to locoregional therapy, Child-Pugh A, previously treated by sorafenib\n\n          -  Histologically confirmed metastatic or advanced ovarian epithelial, fallopian tube or\n             primary peritoneal cavity cancer, progression within 6 months of a platinum\n             containing chemotherapy regimen\n\n          -  Histologically confirmed metastatic renal cell cancer, previously treated with at\n             least one vascular endothelial growth factor (VEGF) inhibitor, at most two prior\n             targeted therapies\n\n          -  Histologically confirmed metastatic or advanced gastric cancer after one line of\n             chemotherapy containing platinum and fluoropyrimidine\n\n        Exclusion Criteria:\n\n          -  Other primary malignancy within the past 3 years (except for fully resected non\n             melanoma skin cancer, localised prostate cancer with normal prostate specific antigen\n             level, or cervical cancer in situ)\n\n          -  Malabsorption (other than in Cohort G patients and partial or complete gastrectomy)\n             or intestinal obstruction\n\n          -  History of pancreatitis\n\n          -  History of myocardial infarction, unstable angina, congestive heart failure New York\n             Heart Association class III/IV, cerebrovascular accident, transient ischaemic attack,\n             limb claudication at rest in the previous 6 months, or ongoing symptomatic\n             dysrhythmias, or uncontrolled atrial, or ventricular arrhythmias, or uncontrolled\n             hypertension defined as systolic blood pressure \u2265150 mmHg or diastolic blood pressure\n             \u226590 mmHg"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "196", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01743469", 
            "org_study_id": "8-55-58102-004"
        }, 
        "intervention": {
            "arm_group_label": "Tasquinimod", 
            "intervention_name": "Tasquinimod", 
            "intervention_type": "Drug", 
            "other_name": "1 capsule:initially at 0.5 mg/day, increasing to 1 mg/day, maintaining 0.5mg/day or decreasing to 0.25mg after at least 2 weeks."
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 23, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "2650"
                    }, 
                    "name": "Antwerp University Hospital, Wilrijkstraat 10"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium", 
                        "zip": "9000"
                    }, 
                    "name": "Ghent University Hospital, 1K12 IE, De Pintelaan 185"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "3000"
                    }, 
                    "name": "Leuven cancer institute (LKI), Herestraat"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L8V 5C2"
                    }, 
                    "name": "Juravinski Cancer Centre, 699 Concession St"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N6A 4L6"
                    }, 
                    "name": "London Health Sciences Center, 790 Commissoners Road East"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mississauga", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L5M 2N1"
                    }, 
                    "name": "The Credit Valley Hospital and Trillium Health Centre, 2200 Eglinton Ave. West"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 2M9"
                    }, 
                    "name": "Princess Margaret, 610 University Avenue"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M4N 3M5"
                    }, 
                    "name": "Sunnybrook, 2075 Bayview Avenue, Suite T2049"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Calgary", 
                        "country": "Canada", 
                        "zip": "T2S 3C3"
                    }, 
                    "name": "Tom Baker Cancer Center, 2210-2nd Street SW"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "zip": "H2L 4M1"
                    }, 
                    "name": "CHUM, Hopital Notre Dame, 1560 Sherbrooke Street East"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec", 
                        "country": "Canada", 
                        "zip": "G1R 2J6"
                    }, 
                    "name": "Hotel-Dieu de Quebec, 11 Cote du Palais"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clichy", 
                        "country": "France", 
                        "zip": "92110"
                    }, 
                    "name": "Hospital Beaujon, 100 Blvd du G\u00e9n\u00e9ral Leclerc"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille cedex", 
                        "country": "France", 
                        "zip": "59020"
                    }, 
                    "name": "Centre Oscar Lambret, 3 rue Fr\u00e9d\u00e9ric Combemale"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69008"
                    }, 
                    "name": "Bureau d'Etudes Cliniques du Centre L\u00e9on B\u00e9rard, 28, rue Laennec"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75015"
                    }, 
                    "name": "Hopital Europeen Georges-Pompidou, AP-HP, 20 Rue Leblanc"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75012"
                    }, 
                    "name": "Hospital Saint-Antoine, 184 rue du Faubourg St Antoine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes cedex", 
                        "country": "France", 
                        "zip": "35042"
                    }, 
                    "name": "Centre Eugene Marquis, Avenue bataille Flandres Dunkerque"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "Centre Ren\u00e9 Gauducheau, Boulevard Jacques Monod"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "94805"
                    }, 
                    "name": "Institute Gustave-Roussy, 114 rue Edouard Vaillant"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08003"
                    }, 
                    "name": "Hospital del mar, Paseo Maritimo 25-29"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28034"
                    }, 
                    "name": "MD Anderson Cancer Centre, Ctra. Colmenar Viejo Km. 9 100,"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28007"
                    }, 
                    "name": "Hospital Gregorio Mara\u00f1on, Dr. Esquerdo, 44-46"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28045"
                    }, 
                    "name": "Hospital Univ La Paz, Paseo Castellana 261"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "zip": "G12 0YN"
                    }, 
                    "name": "Beatson West of Scotland Cancer Centre, 1053 Great Western Road"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leicester", 
                        "country": "United Kingdom", 
                        "zip": "LE5 4PW"
                    }, 
                    "name": "Leicester General Hospital, Gwndolen Road"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SM2 5PT"
                    }, 
                    "name": "The Royal Marsden Hospital, Downs Rd, Sutton"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom", 
                        "zip": "M20 4BX"
                    }, 
                    "name": "The Christie Hospital, Wilmslow Road, Withington"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle-upon-Tyne", 
                        "country": "United Kingdom", 
                        "zip": "NE7 7DN"
                    }, 
                    "name": "Freeman Hospital, Freeman Road, High Heaton"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Southampton", 
                        "country": "United Kingdom", 
                        "zip": "SO16 6YD"
                    }, 
                    "name": "Southampton General Hospital, Tremona Road, Shirley"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Canada", 
                "France", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multicentre, Open Label, Early Stopping Design, Proof Of Concept Study With Tasquinimod In Treating Patients With Advanced Or Metastatic Hepatocellular, Ovarian, Renal Cell And Gastric Carcinomas.", 
        "overall_contact": {
            "email": "clinical.trials@ipsen.com", 
            "last_name": "Ipsen Recruitment Enquiries"
        }, 
        "overall_official": {
            "affiliation": "Ipsen", 
            "last_name": "Nathalie GERMANN, M.D.", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "Canada: Health Canada"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Progression free survival [PFS] rate, defined as the proportion of patients who have neither progressed nor died as measured by RECIST v1.1 (both Cohorts H and R)", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "measure": "Progression free survival [PFS] rate, defined as the proportion of patients who have neither progressed nor died as measured by RECIST v1.1 (Cohort G)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Progression free survival [PFS] rate, defined as the proportion of patients who have neither progressed nor died as measured by RECIST v1.1 (Cohort O)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01743469"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Response rate, defined by RECIST v1.1 (Cohorts H, R and O) and Choi criteria (Cohort H)", 
                "safety_issue": "No", 
                "time_frame": "Every 8 weeks until disease progression, up to 45 months"
            }, 
            {
                "measure": "Response rate, defined by RECIST v1.1 (Cohort G)", 
                "safety_issue": "No", 
                "time_frame": "Every 6 weeks until disease progression, up to 45 months"
            }, 
            {
                "description": "Clinical benefit defined as complete response + partial response + stable disease lasting at least 12 weeks", 
                "measure": "Clinical benefit (Cohorts H, R and O)", 
                "safety_issue": "No", 
                "time_frame": "Every 8 weeks until disease progression, up to 45 months"
            }, 
            {
                "description": "Clinical benefit defined as complete response + partial response + stable disease lasting at least 12 weeks", 
                "measure": "Clinical benefit (Cohort G)", 
                "safety_issue": "No", 
                "time_frame": "Every 6 weeks until disease progression, up to 45 months"
            }, 
            {
                "description": "PFS defined as the time from first study treatment to progression or death due to any cause", 
                "measure": "Time to Progression Free Survival (PFS), (Cohorts H, R and O)", 
                "safety_issue": "No", 
                "time_frame": "Every 8 weeks until disease progression, up to 45 months"
            }, 
            {
                "description": "PFS defined as the time from first study treatment to progression or death due to any cause", 
                "measure": "Time to Progression Free Survival (PFS), (Cohort G)", 
                "safety_issue": "No", 
                "time_frame": "Every 6 weeks until disease progression, up to 45 months"
            }, 
            {
                "description": "TTP defined as the time from first study treatment to disease progression", 
                "measure": "Time to Progression (TTP), (Cohorts H, R and O)", 
                "safety_issue": "No", 
                "time_frame": "Every 8 weeks until disease progression, up to 45 months"
            }, 
            {
                "description": "TTP defined as the time from first study treatment to disease progression", 
                "measure": "Time to Progression (TTP), (Cohort G)", 
                "safety_issue": "No", 
                "time_frame": "Every 6 weeks until disease progression, up to 45 months"
            }, 
            {
                "measure": "Overall survival (OS), defined as the time from first study treatment to death due to any cause.", 
                "safety_issue": "No", 
                "time_frame": "Time from first study treatment to death, up to 45 months"
            }
        ], 
        "source": "Ipsen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ipsen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}